These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 16983342

  • 1. Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination.
    Trivedi AK, Bararia D, Christopeit M, Peerzada AA, Singh SM, Kieser A, Hiddemann W, Behre HM, Behre G.
    Oncogene; 2007 Mar 15; 26(12):1789-801. PubMed ID: 16983342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
    Liu YN, Kang BB, Chen JH.
    Oncogene; 2004 Jan 08; 23(1):278-88. PubMed ID: 14712233
    [Abstract] [Full Text] [Related]

  • 4. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD.
    Mol Cancer Res; 2005 Oct 08; 3(10):585-96. PubMed ID: 16254192
    [Abstract] [Full Text] [Related]

  • 5. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding.
    Cleaves R, Wang QF, Friedman AD.
    Oncogene; 2004 Jan 22; 23(3):716-25. PubMed ID: 14737106
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nuclear redistribution of TCERG1 is required for its ability to inhibit the transcriptional and anti-proliferative activities of C/EBPalpha.
    Banman SL, McFie PJ, Wilson HL, Roesler WJ.
    J Cell Biochem; 2010 Jan 01; 109(1):140-51. PubMed ID: 19911371
    [Abstract] [Full Text] [Related]

  • 8. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction.
    Yang L, Jiang Y, Wu SF, Zhou MY, Wu YL, Chen GQ.
    Carcinogenesis; 2008 Feb 01; 29(2):291-8. PubMed ID: 18024476
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation.
    Nanri T, Uike N, Kawakita T, Iwanaga E, Mitsuya H, Asou N.
    Genes Chromosomes Cancer; 2010 Mar 01; 49(3):237-41. PubMed ID: 19953636
    [Abstract] [Full Text] [Related]

  • 11. E3 ligase SCFSKP2 ubiquitinates and degrades tumor suppressor C/EBPα in acute myeloid leukemia.
    Thacker G, Mishra M, Sharma A, Singh AK, Sanyal S, Trivedi AK.
    Life Sci; 2020 Sep 15; 257():118041. PubMed ID: 32622945
    [Abstract] [Full Text] [Related]

  • 12. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
    Kodama Y, Taura K, Miura K, Schnabl B, Osawa Y, Brenner DA.
    Gastroenterology; 2009 Apr 15; 136(4):1423-34. PubMed ID: 19249395
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
    Hong Q, Hsu LJ, Schultz L, Pratt N, Mattison J, Chang NS.
    BMC Mol Biol; 2007 Jun 13; 8():50. PubMed ID: 17567906
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell.
    Schuster MB, Porse BT.
    Biofactors; 2009 Jun 13; 35(3):227-31. PubMed ID: 19322763
    [Abstract] [Full Text] [Related]

  • 18. c-Jun NH2-terminal kinase decreases ubiquitination and promotes stabilization of p21(WAF1/CIP1) in K562 cell.
    Fan Y, Chen H, Qiao B, Liu Z, Luo L, Wu Y, Yin Z.
    Biochem Biophys Res Commun; 2007 Mar 30; 355(1):263-8. PubMed ID: 17292858
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2.
    Chen KC, Chiou YL, Chang LS.
    J Cell Biochem; 2009 Oct 15; 108(3):612-20. PubMed ID: 19670268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.